The Lynx Group

COVID-19 & Cancer

According to data from a European registry, approximately 1 in 6 patients with cancer who recovered from COVID-19 infection experienced long-term sequelae (ie, “long-haul” COVID-19), placing them at increased risk for death or discontinuation of anticancer treatment.
Read Article


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: